Osaka University, Graduate School of Medicine
Osaka, 565-0871, Japan
NCT Number: NCT01862276
To investigate the prognosis due to presence or absence of bile duct resection in intrahepatic cholangiocarcinoma that require hepatic lobectomy.
Looking for future studies?
Notify MeAll sexes
Observational
Osaka, 565-0871, Japan
The bile duct resection in hepatic lobectomy due to cholangiocarcinoma, mass forming type, is still controversial. We retrospectively evaluated the effect of bile duct resection in this surgery.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: 11 years (2000-2010)
Time frame: 11 years
Kansai Hepatobiliary Oncology Group
Network
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01862315
Adenocarcinoma, Carcinoma
Basking Ridge, New Jersey, United States
View Trial DetailsNCT04834674
Adenocarcinoma, Apatinib
Chengdu, Sichuan, China
View Trial DetailsNCT04526106
Adenocarcinoma, Carcinoma
Birmingham, Alabama, United States
View Trial DetailsNCT05328167
Adenocarcinoma, Carcinoma
Philadelphia, Pennsylvania, United States
View Trial Details